Get the Stockscreener App
11.97
8.82%
0.97
After Hours:
12.17
0.20
+1.67%
Teladoc Health Inc stock is traded at $11.97, with a volume of 18.44M.
It is up +8.82% in the last 24 hours and up +20.54% over the past month.
Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.
See More
Previous Close:
$11.00
Open:
$11.11
24h Volume:
18.44M
Relative Volume:
3.52
Market Cap:
$2.06B
Revenue:
$2.59B
Net Income/Loss:
$-981.73M
P/E Ratio:
-2.0745
EPS:
-5.77
Net Cash Flow:
$206.95M
1W Performance:
+15.76%
1M Performance:
+20.54%
6M Performance:
+59.81%
1Y Performance:
-40.36%
1-Day Range:
$10.81
$12.67
1-Week Range:
$9.72
$12.67
52-Week Range:
$6.76
$21.74
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
2 MANHATTANVILLE ROAD, PURCHASE, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
11.97 | 2.06B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
239.43 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.78 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
58.26 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
64.99 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.07 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Why Teladoc Stock Surprisingly Popped Today - Yahoo! Voices
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
Teladoc Makes Strategic Move: Awards 35K Shares to Secure Top Industry Talent - StockTitan
Teladoc acquires Catapult Health for $65M - Crain's New York Business
Teladoc Health Stock Soars. Why It’s An ‘Under-the-Radar AI Play.’ - Barron's
Teladoc shares rise on positive Citron Research outlook By Investing.com - Investing.com Canada
Teladoc shares rise on positive Citron Research outlook - Investing.com
Virtual Patient Care Solutions Market Growing Trends - openPR
Teladoc Health Buys Catapult Health In $65M Acquisition - MSN
Telemedicine Market Report Analysis and Research Studies: Key - openPR
Needham maintains hold on Teladoc stock post Catapult Health buy - MSN
Why Teladoc Health Stock Crashed Again in 2024 - AOL
Teladoc Health stock rises following Catapult Health acquisition By Investing.com - Investing.com Canada
Teladoc’s $65M Catapult Health Deal Wins Over Retail As Stock Eyes Best Day In Over 2 Months - Asianet Newsable
Teladoc Health to Acquire Catapult Health in $65 Million Deal to Expand Virtual Preventive Care - Yahoo Finance
M&A News: Teladoc Health (NASDAQ:TDOC) To Buy Catapult Health - TipRanks
Teladoc Health to acquire Catapult Health in $65M all-cash deal - MSN
Teladoc call volume above normal and directionally bullish - TipRanks
BofA raises Teladoc stock target to $11.50, maintains neutral stance - MSN
Teladoc to acquire virtual care company Catapult Health for $65M - Healthcare Dive
BofA raises Teladoc stock target to $11.50, maintains neutral stance By Investing.com - Investing.com Nigeria
Purchase-Based Teladoc Expands Early Disease Detection For 90M+ Patients With $65M Deal - Daily Voice
Teladoc Health, Inc. signed a definitive agreement to acquire Catapult Health for $70 million. - Marketscreener.com
Teladoc Health to acquire Catapult Health in $65 million deal - MSN
Teladoc Health to Buy Catapult Health for $65 Million - MarketWatch
Teladoc Health to Acquire Catapult Health, Advancing Integrated Care Strategy -February 05, 2025 at 07:38 am EST - Marketscreener.com
Teladoc Health to acquire Catapult Health in all-cash transaction for $65M - TipRanks
Teladoc Health to Acquire Catapult Health, Advancing Integrated Care Strategy - GlobeNewswire
Teladoc to buy home testing company Catapult for $65 million - STAT
Teladoc Health to Acquire Catapult Health, Advancing Integrated Care Strategy - Benzinga
Teladoc's Strategic $65M Acquisition Unlocks Virtual Health Revolution in Preventive Care - StockTitan
Telehealth Services Market Projected To Witness Substantial - openPR
Best Telemedicine Services for 2025 - CNET
Teladoc Health Inc (TDOC) Stock Price Up 3.08% on Feb 4 - GuruFocus.com
Digital health companies pitch employers on cutting GLP-1 costs - Modern Healthcare
Virtual Health Service Market Is Booming Worldwide 2025-2032: Babylon Health, eVisit, HealthTap, American - EIN News
Robeco Institutional Asset Management B.V. Raises Holdings in Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
(TDOC) Technical Data - Stock Traders Daily
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - Nasdaq
Teladoc Health to Announce Fourth Quarter 2024 Financial Results - The Manila Times
Teladoc Health Inc. to Release Fourth Quarter 2024 Results and Host Conference Call on February 26, 2025 - Nasdaq
Murphy Pohlad Asset Management LLC Invests $458,000 in Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Teladoc Health Expands & Moves Headquarters to 10 Grand Central - COMMERCIALCafé
U.S. Digital Therapeutics Market Growth in Future Scope - openPR
Teladoc Health, Inc. (TDOC): Enhancing Virtual Healthcare with Generative AI - MSN
Future-Proofing Growth of Virtual Management of Serious - openPR
10 AI News And Ratings on Wall Street’s Radar - Insider Monkey
Teladoc Health, Inc. (TDOC): Is This Healthcare Stock A Good Buy? - Insider Monkey
Teladoc Partners With Amazon to Expand Chronic Care Program Reach - MSN
Recent uptick might appease Teladoc Health, Inc. (NYSE:TDOC) institutional owners after losing 50% over the past year - Yahoo Finance
Q3 Earnings Highs And Lows: Teladoc (NYSE:TDOC) Vs The Rest Of The Online Marketplace Stocks - Yahoo Finance
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.54%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):